000 | 01309 a2200325 4500 | ||
---|---|---|---|
005 | 20250517093102.0 | ||
264 | 0 | _c20170403 | |
008 | 201704s 0 0 eng d | ||
022 | _a1432-1262 | ||
024 | 7 |
_a10.1007/s00384-016-2593-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Xiang | |
245 | 0 | 0 |
_aDual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials. _h[electronic resource] |
260 |
_bInternational journal of colorectal disease _cSep 2016 |
||
300 |
_a1655-6 p. _bdigital |
||
500 | _aPublication Type: Letter; Meta-Analysis | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 | _aWithholding Treatment |
700 | 1 | _aWang, Min | |
700 | 1 | _aLiu, Gui-Yang | |
700 | 1 | _aMa, Jian-Li | |
773 | 0 |
_tInternational journal of colorectal disease _gvol. 31 _gno. 9 _gp. 1655-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00384-016-2593-7 _zAvailable from publisher's website |
999 |
_c25973111 _d25973111 |